A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

Hospitals and contract pharmacies are not required to pass those savings directly to patients at the pharmacy counter. | ...

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely ...

The Washington state House Appropriations Committee has advanced a bill concerning a federal drug pricing program known as ...

The American Hospital Association's initial comment on the Health Resources and Services Administration’s (HRSA) request for information regarding a 340B Rebate Model Pilot Program.

AHA urges HHS to block Novo Nordisk's 340B data demand, citing legal and cost concerns for safety-net hospitals and covered ...

On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...